ClinicalTrials.Veeva

Menu

Everyday Exposures: How Chemicals and Weight Impact Breast Cancer Risk

M.D. Anderson Cancer Center logo

M.D. Anderson Cancer Center

Status

Enrolling

Conditions

Breast Cancer

Treatments

Other: Surveys
Other: Video

Study type

Observational

Funder types

Other

Identifiers

NCT07137468
2025-0698
NCI-2025-06013 (Other Identifier)

Details and patient eligibility

About

To learn about breast cancer survivor's knowledge of and interest in learning about environmental exposures related to personal care products. Researchers also want to learn if there is a link between excessive weight and chemicals that may affect hormones.

Full description

Primary Objectives:

Excessive body weight, endocrine disrupting chemicals (EDCs), and breast cancer are interconnected through disruptions in hormone balance, with notable disparities in risk and outcomes for under-resourced communities. Excessive weight is a risk factor for breast cancer particularly in postmenopausal individuals, primarily due to increased estrogen production from adipose tissue.

EDCs, such as parabens, bisphenols, and phthalates, have been implicated in both excessive weight and breast cancer, particularly in hormone-sensitive breast cancer subtypes. These non-persistent chemicals are commonly found in personal care products, such as cosmetics and hair care items. Parabens have been shown to promote pro-tumorigenic effects in luminal breast cancer cells, raising concerns about their role in breast cancer incidence. Research has also highlighted that African American individuals face higher exposure to EDCs, especially through hair and other personal care products marketed to people of color, which may contribute to disparities in breast cancer risk.

The relationship between weight and breast cancer is complex with differences in body mass index influencing risk. Under-resourced groups are more likely to be diagnosed with aggressive late-stage breast cancer, a risk further exacerbated by high body weight. Moreover, disparities in healthcare access, economic and social standing, and exposure to EDCs, also known as non-medical drivers of health (NMDOH), may compound breast cancer mortality rates in these communities.

The overall goal of this proposal is to engage participants from the ALAC program and determine their knowledge and interest in environmental exposure education focused on personal care products. The information gained from our efforts will support the development of the Active Living After Cancer with Environmental Vitality (ALAC-ENV) intervention to improve QOL.

Additionally, we will determine the association between prevalent EDCs and excessive weight for breast cancer survivors. To achieve this goal, we will pursue the following specific aims:

Specific Aim 1: Determine breast cancer survivors' environmental exposure knowledge. Participants (n=30; pilot-tested group (n=6-8)) will participate in focus group interviews to assess their interest and understanding of environmental exposures with an emphasis on personal care products. Participants in the pilot-testing group will assist with potential modifications regarding the focus group guide. Participants in the pilot-testing group will be recognized as "Focus Group 1" participants and will complete all protocol procedures.

Specific Aim 2: Determine the relationship between exposures to prevalent EDCs and BMI. A cross-sectional design to examine associations between BMI and measurements of non-persistent EDCs in urine samples of cancer survivors.

Emerging evidence on the disproportionate exposure to carcinogenic chemicals and its role in cancer-related disparities underscores the need for this study. The limited understanding of the relationship between EDCs and weight-related cancers further highlights the importance of exploring pathways to mitigate health risks in under-resourced communities. Findings from this study will inform an R-level grant to develop a randomized trial testing the efficacy of an adapted ALAC-ENV curriculum for dissemination and implementation in community settings. Additionally, we will seek foundation grant support for a cross-sectional study examining the association between body mass index, EDC exposure, and cancer in Acres Homes within the context of NMDOH.

Enrollment

30 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Be a resident of Acres Home community
  2. Be 18 years of age and older
  3. Current or former participants of the ALAC program
  4. Self-report a breast cancer diagnosis including subtypes
  5. Able to communicate in English

Exclusion criteria

  1. Self-report metastatic breast cancer diagnosis
  2. Unable to communicate in English

Trial design

30 participants in 3 patient groups

Pre-Focus Group Survey
Description:
Before your focus group session, you will complete computer-based surveys about your age, biological sex, gender, income, highest level of education, marital status, insurance status, and health behaviors. The online surveys may take up to 40 minutes to complete.
Treatment:
Other: Surveys
Focus Group Session
Description:
After completing the pre-focus group surveys, you will be assigned to a focus group. The focus group will include a warm-up discussion (10 minutes), a short audiovisual presentation (5 minutes) describing endocrine-disrupting chemicals (EDCs), and open-ended questions facilitating discussions on environmental exposures and personal care product usage and ALAC program from your perspective (75 minutes). Focus groups will occur by Zoom video conferencing and will be audio- and video-recorded. The recording will be transcribed (written down) word-for-word, but without your name or any other identifying information. The digital audio and video files will be destroyed after they are transcribed.
Treatment:
Other: Video
Post-Focus Group Survey
Description:
After your focus group session, you will complete a computer-based survey to help researchers understand the products you use and things that you do in your everyday life. You will also complete a questionnaire asking about the products you've used in the last 24 hours using the Clearya app. The Clearya app captures the ingredients in the products you use by taking pictures or videos of your products. You will be asked to answer 3 questions for each product scanned. The online surveys may take up to 40 minutes to complete.
Treatment:
Other: Surveys

Trial contacts and locations

1

Loading...

Central trial contact

Dede Teteh-Brooks, DRPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems